Skip to main content
SpringerLink
Log in

Shaping the future of safer innovative drugs in Europe

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Anonymous. Nat. Biotechnol. 29, 551 (2011).

  2. Richard, A.M. Chem. Res. Toxicol. 19, 1257–1262 (2006).

    Article  CAS  Google Scholar 

  3. Nigsch, F., Macaluso, N.J.M., Mitchell, J.B.O. & Zmuidinavicius, D. Expert Opin. Drug Metab. Toxicol. 5, 1–14 (2009).

    Article  CAS  Google Scholar 

  4. Merlot, C. Drug Discov. Today 15, 16–22 (2010).

    Article  CAS  Google Scholar 

  5. Rusyn, I. & Daston, G.P. Environ. Health Perspect. 118, 1047–1050 (2010).

    Article  Google Scholar 

  6. Gasteiger, J. (ed.). Handbook of Chemoinformatics—From Data to Knowledge (Wiley-VCH: Weinheim, 2003).

    Book  Google Scholar 

  7. Gasteiger, J. J. Med. Chem. 49, 6429–6434 (2006).

    Article  CAS  Google Scholar 

  8. Vaz, R.J. et al. Expert Opin. Drug Metab. Toxicol. 6, 851–861 (2010).

    Article  CAS  Google Scholar 

  9. Bonn, B., Leandersson, C., Fontaine, F. & Zamora, I. Rapid Commun. Mass Spectrom. 24, 3127–3138 (2010).

    Article  CAS  Google Scholar 

  10. Wolber, G. & Langer, T. J. Chem. Inf. Model. 45, 160–169 (2005).

    Article  CAS  Google Scholar 

  11. Wolber, G., Domhofer, A. & Langer, T. J. Comput. Aided Mol. Des. 20, 773–788 (2006).

    Article  CAS  Google Scholar 

  12. Mestres, J., Gregori-Puigjané, E., Valverde, S. & Solé, R.V. Nat. Biotechnol. 26, 983–984 (2008).

    Article  CAS  Google Scholar 

  13. Garcia-Serna, R. & Mestres, J. Expert Opin. Drug Metab. Toxicol. 6, 1253–1263 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chemotargets, IMIM-Hospital del Mar,

    Jordi Mestres

  2. University Pompeu Fabra, Barcelona, Catalonia, Spain

    Jordi Mestres

  3. Inte:Ligand, Vienna, Austria

    Sharon D Bryant

  4. Lead Molecular Design, Sant Cugat del Vallès, Spain

    Ismael Zamora

  5. Molecular Networks, Erlangen, Germany

    Johann Gasteiger

Authors
  1. Jordi Mestres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon D Bryant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ismael Zamora
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johann Gasteiger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jordi Mestres.

Ethics declarations

Competing interests

J.M. is the president of Chemotargets, S.D.B. is the CEO of Inte:Ligand, I.E. is the CEO of Lead Molecular Design and J.G. is the president of Molecular Networks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mestres, J., Bryant, S., Zamora, I. et al. Shaping the future of safer innovative drugs in Europe. Nat Biotechnol 29, 789–790 (2011). https://doi.org/10.1038/nbt.1973

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1973

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation